Search alternatives:
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
mean decrease » a decrease (Expand Search)
a large » _ large (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
mean decrease » a decrease (Expand Search)
a large » _ large (Expand Search)
-
16621
-
16622
-
16623
-
16624
-
16625
-
16626
-
16627
-
16628
A Fractional Bond Order of 1/2 in Pd<sub>2</sub><sup>5+</sup>−Formamidinate Species; The Value of Very High-Field EPR Spectra
Published 2007“…Upon oxidation of the precursor, the Pd−Pd distance decreases by 0.052 Å from 2.6486(8) to 2.597(1) Å. …”
-
16629
-
16630
Behavioral and subjective data.
Published 2015“…<p>A) Force profile (average of 50 trials) of the baseline (dashed lines) and final (solid lines) sessions in one subject of the experimental group (red lines) and one subject of the control group (green lines). …”
-
16631
Weight and Glucose Reduction Observed with a Combination of Nutritional Agents in Rodent Models Does Not Translate to Humans in a Randomized Clinical Trial with Healthy Volunteers...
Published 2016“…In subjects with diabetes taking metformin, weight increased in the GSK457-treated group [adjusted mean % increase from baseline: 1.26% (95% CI: -0.24, 2.75)], and mean glucose and HbA1c were decreased slightly compared to placebo [adjusted mean glucose change from baseline: -1.22 mmol/L (95% CI: -2.45, 0.01); adjusted mean HbA1c change from baseline: -0.219% (95% CI: -0.910, 0.472)].…”
-
16632
-
16633
-
16634
-
16635
-
16636
-
16637
-
16638
-
16639
-
16640
Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization
Published 2018“…Conclusions: This study demonstrates that both subconjunctival and topical administrations of bevacizumab inhibit corneal neovascularization and decrease inflammation and fibroblast activity in a rat model of corneal neovascularization induced by alkali burn.…”